How Has the Gene Expression Market Size Evolved in Recent Years?
The gene expression market has seen considerable growth due to a variety of factors.
• In recent years, the gene expression market has seen swift expansion. The market, which was worth $11.55 billion in 2024, is expected to increase to $12.79 billion in 2025, representing a compound annual growth rate (CAGR) of 10.7%. The rise in market size throughout the historic period is due to an enhanced focus on precision medicine, advancements in cancer research and biomarker discovery, its use in diagnosing and projecting diseases combined with system biology methods, as well as the necessities of drug discovery and development.
What are the Market Size and Expected Growth Rates for the Gene Expression Market?
The Gene Expression market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size for gene expression is predicted to experience swift expansion. The projected growth is to reach $20.25 billion by 2029 with a compound annual growth rate (CAGR) of 12.2%.
The factors contributing to this growth during the forecast period include the emergence of spatial transcriptomics, an increase in epigenomic studies, global health events and readiness for pandemics, interest in non-coding RNA exploration, and greater use in immunotherapy research. The forecast period also expects major trends such as single-cell RNA sequencing, advancements in next-generation sequencing, the integration of multi-omics data, progress in gene editing technologies, the development of liquid biopsy, and spatial omics in drug discovery.
Which Key Drivers Are Propelling The Gene Expression Market's Growth?
The forward momentum of the gene expression market is expected to be fueled by a growing attention on precision medicine. Precision medicine exploits information about an individual's gene or protein to prevent, diagnose, or treat diseases. It uses gene expression to spot irregularities in normal operation and physiological regulation of a person, which is achieved by measuring and comparing different genes and transcripts in tissues associated with various health conditions. This approach enhances patient-centric therapy. For example, in February 2023, a report by the Personalized Medicine Coalition (PMC), a nonprofit based in the US, stated that personalized medicines accounted for 35% of all newly approved NMEs in 2021. This trend continued in 2022 with 12 new approvals, maintaining a steady quarter of new drug approvals over the last eight years, a significant leap from less than 10% a decade prior. Consequently, the ramped-up emphasis on precision medicine is propelling the gene expression market.
What Are The Key Segments Within The Global Gene Expression Market?
The gene expression market covered in this report is segmented –
1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products
2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation
3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis
4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications
Subsegments:
1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents
2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays,
3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables
Pre-Book The Gene Expression Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Gene Expression Market?
The progress in technology is a significant trend within the gene expression market. Leading corporations in this niche are leaning towards RNA gene expression technique development. As an example, Enzo Biochem, Inc, an American powerhouse in biosciences and diagnostics, launched the AMPIVIEW platform in September 2022. This platform is primed for exceptional sensitivity in the identification and illustration of biomarkers in cells and tissue samples. Utilizing in-situ hybridization technology, AMPIVIEW, an RNA gene expression tool, facilitates the detection of HPV and SARS-CoV-2. It ensures precise and sensitive identification of target genes within tissues or cells, while maintaining their morphology.
Who Are the Key Players In The Gene Expression Market?
Major companies operating in the gene expression market include:
• Thermo Fisher Scientific Inc.
• Qiagen NV
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Agilent Technologies Inc.
• PerkinElmer Inc.
• GE Healthcare
• F Hoffmann-La Roche Ltd
• Oxford Gene Technology IP Limited
• Promega Corporation
• OriGene Technologies Inc.
• Luminex Corporation
• Takara Bio Inc.
• Danaher Corporation
• ELITechGroup
• Biocartis Group NV
• Integragen SA
• Oxford Nanopore Technologies Limited
• Phalanx Biotech Group
• Roche Holding AG
• Sengenics Corporation Pte Ltd.
• GenXPro GmbH
• Twist Bioscience Corporation
• Zymo Research Corporation
• Abcam plc.
• Bio-Techne Corporation
What Are The Regional Insights Into The Gene Expression Market?
North America was the largest region in the gene expression market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
